Phenotyping of Leukocytes and Leukocyte-Derived Extracellular Vesicles

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Pugholm, Lotte Hatting ^a   Bæk, Rikke ^a   Søndergaard, Evo Kristina Lindersson ^a   Revenfeld, Anne Louise Schacht ^a   Jørgensen, Malene Møller ^a   Varming, Kim ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; B7 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD37 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD63 ANTIGEN; CD8 ANTIGEN; CD81 ANTIGEN; CD82 ANTIGEN; CD83 ANTIGEN; CD9 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; FIBRINOGEN RECEPTOR; HLA ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 1 RELATED CHAIN A B; PALLADIUM; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; EXOSOME; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE CULTURE; LEUKOCYTE DERIVED EXTRACELLULAR VESICLE; MONOCULTURE; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; CASE CONTROL STUDY; CELL CULTURE; CELL LINEAGE; IMMUNOPHENOTYPING; METABOLISM;

ANTIGENS, CD; BIOMARKERS; CASE-CONTROL STUDIES; CELL LINEAGE; CELLS, CULTURED; EXTRACELLULAR VESICLES; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES; PHENOTYPE;

EID: 84971556305     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/6391264     Document Type: Article

References (64)

1. A. L. S. Revenfeld, R. Bæk, M. H. Nielsen, A. Stensballe, K. Varming, and M. Jørgensen, "Diagnostic and prognostic potential of extracellular vesicles in peripheral blood, " Clinical Therapeutics, vol. 36, no. 6, pp. 830-846, 2014.
2. M. Yáñez-Mó, P. R.-M. Siljander, Z. Andreu et al., "Biological properties of extracellular vesicles and their physiological functions, " Journal of Extracellular Vesicles, vol. 4, Article ID27066, 2015.
3. C. Théry, L. Zitvogel, and S. Amigorena, "Exosomes: composition, biogenesis and function, "Nature Reviews Immunology, vol. 2, no. 8, pp. 569-579, 2002.
4. S. J. GouldandG. Raposo, "Aswewait: copingwithanimperfect nomenclature for extracellular vesicles, " Journal of Extracellular Vesicles, vol. 2, Article ID20389, 2013.
5. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, " Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
6. K. Denzer, M. J. Kleijmeer, H. F. G. Heijnen, W. Stoorvogel, and H. J. Geuze, "Exosome: from internal vesicle of the multivesicular body to intercellular signaling device, " Journal of Cell Science, vol. 113, part 19, pp. 3365-3374, 2000.
7. C. Théry, M. Ostrowski, and E. Segura, "Membrane vesicles as conveyors of immune responses, " Nature Reviews Immunology, vol. 9, no. 8, pp. 581-593, 2009.
8. V. Huber, P. Filipazzi, M. Iero, S. Fais, and L. Rivoltini, "More insights into the immunosuppressive potential of tumor exosomes, " Journal of TranslationalMedicine, vol. 6, article63, 2008.
9. M. Iero, R. Valenti, V. Huber et al., "Tumour-released exosomes and their implications in cancer immunity, " Cell Death and Differentiation, vol. 15, no. 1, pp. 80-88, 2008.
10. M. P. Oksvold, A. Kullmann, L. Forfang et al., "Expression of B-Cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells, " Clinical Therapeutics, vol. 36, no. 6, pp. 847. e1-862. e1, 2014.
11. V. Muralidharan-Chari, J. W. Clancy, A. Sedgwick, and C. D'Souza-Schorey, "Microvesicles: mediators of extracellular communication during cancer progression, " Journal of Cell Science, vol. 123, no. 10, pp. 1603-1611, 2010.
12. R. Valenti, V. Huber, P. Filipazzi et al., "Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-mediated suppressive activity on T lymphocytes, " Cancer Research, vol. 66, no. 18, pp. 9290-9298, 2006.
13. D. D. Taylor, C. Gerçel-Taylor, K. S. Lyons, J. Stanson, and T. L. Whiteside, "T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containingmembrane vesicles shed from ovarian tumors, " Clinical Cancer Research, vol. 9, no. 14, pp. 5113-5119, 2003.
14. M. Mack, A. Kleinschmidt, H. Brühl et al., "Transfer of the chemokine receptor CCR5 between cells bymembrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection, " Nature Medicine, vol. 6, no. 7, pp. 769-775, 2000.
15. T. Wurdinger, N. N. Gatson, L. Balaj, B. Kaur, X. O. Breakefield, and D. M. Pegtel, "Extracellular vesicles and their convergence with viral pathways, " Advances in Virology, vol. 2012, Article ID 767694, 12 pages, 2012.
16. M. Mittelbrunn, C. Gutíerrez-Vázquez, C. Villarroya-Beltri et al., "Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, " Nature Communications, vol. 2, no. 1, article 282, 2011.
17. C. Admyre, S. M. Johansson, S. Paulie, and S. Gabrielsson, "Direct exosome stimulation of peripheral human T cells detected by ELISPOT, " European Journal of Immunology, vol. 36, no. 7, pp. 1772-1781, 2006.
18. M. Eldh, K. Ekström, H. Valadi et al., "Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA, " PLoS ONE, vol. 5, no. 12, Article ID e15353, 2010.
19. S. C. Saunderson, P. C. Schuberth, A. C. Dunn et al., "Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor, " The Journal of Immunology, vol. 180, no. 12, pp. 8146-8152, 2008.
20. L. Lugini, S. Cecchetti, V. Huber et al., "Immune surveillance properties of human NK cell-derived exosomes, " Journal of Immunology, vol. 189, no. 6, pp. 2833-2842, 2012.
21. Y. Xie, X. Zhang, T. Zhao, W. Li, and J. Xiang, "Natural CD8+25+ regulatory T cell-secreted exosomes capable of suppressing cytotoxic T lymphocyte-mediated immunity against B16 melanoma, " Biochemical and Biophysical Research Communications, vol. 438, no. 1, pp. 152-155, 2013.
22. S. Bhatnagar, K. Shinagawa, F. J. Castellino, and J. S. Schorey, "Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo, " Blood, vol. 110, no. 9, pp. 3234-3244, 2007.
23. E. N. M. Nolte-'t Hoen, S. I. Buschow, S. M. Anderton, W. Stoorvogel, and M. H. M. Wauben, "Activated T cells recruit exosomes secreted by dendritic cells via LFA-1, " Blood, vol. 113, no. 9, pp. 1977-1981, 2009.
24. L. Garzetti, R. Menon, A. Finardi et al., "Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs, " Journal of Leukocyte Biology, vol. 95, no. 5, pp. 817-825, 2014.
25. L. Zitvogel, A. Regnault, A. Lozier et al., "Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes, " Nature Medicine, vol. 4, no. 5, pp. 594-600, 1998.
26. P. Rialland, D. Lankar, G. Raposo, C. Bonnerot, and P. Hubert, "BCR-bound antigen is targeted to exosomes in human follicular lymphoma B-cells, " Biology of the Cell, vol. 98, no. 8, pp. 491-501, 2006.
27. A. Muntasell, A. C. Berger, and P. A. Roche, "T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes, " EMBO Journal, vol. 26, no. 19, pp. 4263-4272, 2007.
28. E. Segura, S. Amigorena, and C. Théry, "Mature dendritic cells secrete exosomes with strong ability to induce antigenspecific effector immune responses, " Blood Cells, Molecules, and Diseases, vol. 35, no. 2, pp. 89-93, 2005.
29. S. Viaud, M. Terme, C. Flament et al., "Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15R, " PLoS ONE, vol. 4, no. 3, Article ID e4942, 2009.
30. S. I. Buschow, E. N. M. Nolte-'t Hoen, G. van Niel et al., "MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways, " Traffic, vol. 10, no. 10, pp. 1528-1542, 2009.
31. S. Hao, J. Yuan, and J. Xiang, "Nonspecific CD4+ T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8+ CTL responses and long-term T cell memory, " Journal of Leukocyte Biology, vol. 82, no. 4, pp. 829-838, 2007.
32. H. Zhang, Y. Xie, W. Li, R. Chibbar, S. Xiong, andJ. Xiang, "CD4 T cell-released exosomes inhibit CD8 cytotoxic T-lymphocyte responses and antitumor immunity, " Cellular and Molecular Immunology, vol. 8, no. 1, pp. 23-30, 2011.
33. O. Ashiru, P. Boutet, L. Fernández-Messina et al., "Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA?008 that is shed by tumor cells in exosomes, " Cancer Research, vol. 70, no. 2, pp. 481-489, 2010.
34. X. Li, J.-J. Li, J.-Y. Yang et al., "Tolerance induction by exosomes from immature dendritic cells and rapamycin in a mouse cardiac allograft model, " PLoS ONE, vol. 7, no. 8, Article ID e44045, 2012.
35. X. Yang, S. Meng, H. Jiang, C. Zhu, and W. Wu, "Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats, " Journal of Surgical Research, vol. 171, no. 2, pp. 826-832, 2011.
36. H. Pêche, M. Heslan, C. Usal, S. Amigorena, and M. C. Cuturi, "Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection, " Transplantation, vol. 76, no. 10, pp. 1503-1510, 2003.
37. M. Jørgensen, R. Bæk, S. Pedersen, E. K. Søndergaard, S. R. Kristensen, and K. Varming, "Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping, " Journal of Extracellular Vesicles, vol. 2, pp. 1-9, 2013.
38. M. M. Jørgensen, R. Bæk, and K. Varming, "Potentials and capabilities of the Extracellular Vesicle (EV) Array, " Journal of Extracellular Vesicles, vol. 4, Article ID 26048, 2015.
39. M. Kornek, Y. Popov, T. A. Libermann, N. H. Afdhal, and D. Schuppan, "Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells, " Hepatology, vol. 53, no. 1, pp. 230-242, 2011.
40. C. Admyre, B. Bohle, S. M. Johansson et al., "B cell-derived exosomes can present allergen peptides and activate allergenspecific T cells to proliferate and produce TH2-like cytokines, " Journal of Allergy and Clinical Immunology, vol. 120, no. 6, pp. 1418-1424, 2007.
41. A. Aharon, T. Tamari, and B. Brenner, "Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells, " Thrombosis and Haemostasis, vol. 100, no. 5, pp. 878-885, 2008.
42. E. van der Vlist, G. J. A. Arkesteijn, C. H. A. van de Lest, W. Stoorvogel, E. N. M. Nolte-'t Hoen, and M. H. M. Wauben, "CD4+ T cell activation promotes the differential release of distinct populations of nanosized vesicles, " Journal of Extracellular Vesicles, vol. 1, Article ID18364, 2012.
43. M. P. Hunter, N. Ismail, X. Zhang et al., "DetectionofmicroRNA expression in human peripheral blood microvesicles, " PLoS ONE, vol. 3, no. 11, Article ID e3694, 2008.
44. B. Clémenceau, R. Vivien, E. Debeaupuis et al., "FcRIIIa (CD16) induction on human t lymphocytes and CD16pos Tlymphocyte amplification, " Journal of Immunotherapy, vol. 34, no. 7, pp. 542-549, 2011.
45. N. K. Björkström, V. D. Gonzalez, K.-J. Malmberg et al., "Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection, "The Journal of Immunology, vol. 181, no. 6, pp. 4219-4228, 2008.
46. D. M. Rose, R. Alon, andM. H. Ginsberg, "Integrinmodulation and signaling in leukocyte adhesion and migration, " Immunological Reviews, vol. 218, no. 1, pp. 126-134, 2007.
47. H. Yusuf-Makagiansar, M. E. Anderson, T. V. Yakovleva, J. S. Murray, and T. J. Siahaan, "Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases, " Medicinal Research Reviews, vol. 22, no. 2, pp. 146-167, 2002.
48. A. Clayton, A. Turkes, S. Dewitt, R. Steadman, M. D. Mason, and M. B. Hallett, "Adhesion and signaling by B cell-derived exosomes: the role of integrins, " The FASEB Journal, vol. 18, no. 9, pp. 977-979, 2004.
49. R. Wubbolts, R. S. Leckie, P. T. M. Veenhuizen et al., "Proteomic and biochemical analyses of human B cell-derived exosomes: potential implications for their function and multivesicular body formation, " The Journal of Biological Chemistry, vol. 278, no. 13, pp. 10963-10972, 2003.
50. H. Peinado, M. Ale?ckovíc, S. Lavotshkin et al., "Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET, " Nature Medicine, vol. 18, no. 6, pp. 883-891, 2012.
51. M. Uhlen, P. Oksvold, L. Fagerberg et al., "Towards a knowledge-based Human Protein Atlas, " Nature Biotechnology, vol. 28, no. 12, pp. 1248-1250, 2010.
52. M. J. Martínez-Lorenzo, A. Anel, S. Gamen et al., "Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles, " Journal of Immunology, vol. 163, no. 3, pp. 1274-1281, 1999.
53. I. Monleón, M. J. Martínez-Lorenzo, L. Monteagudo et al., "Differential secretion of Fas ligand-or APO2 ligand/TNFrelated apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells, " Journal of Immunology, vol. 167, no. 12, pp. 6736-6744, 2001.
54. R. Alonso, C. Mazzeo, M. C. Rodriguez et al., "Diacylglycerol kinase regulates the formation and polarisation of mature multivesicular bodies involved in the secretion of Fas ligandcontaining exosomes in T lymphocytes, " Cell Death and Differentiation, vol. 18, no. 7, pp. 1161-1173, 2011.
55. S. Tsukamoto, M. Takeuchi, T. Kawaguchi et al., "Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes, " Experimental andMolecularMedicine, vol. 46, article e89, 2014.
56. J. M. Tarrant, L. Robb, A. B. van Spriel, and M. D. Wright, "Tetraspanins: molecular organisers of the leukocyte surface, " Trends in Immunology, vol. 24, no. 11, pp. 610-617, 2003.
57. V. Rocha-Perugini, M. Zamai, J. M. González-Granado et al., "CD81 controls sustained T cell activation signaling and defines the maturation stages of cognate immunological synapses, " Molecular and Cellular Biology, vol. 33, no. 18, pp. 3644-3658, 2013.
58. S. C. Todd, S. G. Lipps, L. Crisa, D. R. Salomon, and C. D. Tsoukas, "CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation, " The Journal of Experimental Medicine, vol. 184, no. 5, pp. 2055-2060, 1996.
59. H. T. Maecker, M.-S. Do, and S. Levy, "CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 5, pp. 2458-2462, 1998.
60. A. Gilsanz, L. Sánchez-Martín, M. D. Gutíerrez-López et al., "ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9, " Cellular and Molecular Life Sciences, vol. 70, no. 3, pp. 475-493, 2013.
61. E. Tippett, P. U. Cameron, M. Marsh, and S. M. Crowe, "Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection, " Journal of Leukocyte Biology, vol. 93, no. 6, pp. 913-920, 2013.
62. A. L. Schacht Revenfeld, E. K. Lindersson Søndergaard, A. Stensballe, R. Baek, M. Møller Jørgensen, and K. Varming, "Characterization of a cell-culturing system for the study of contact-independent extracellular vesicle communication, " Journal of Circulating Biomarkers, 2016.
63. M. He, J. Crow, M. Roth, Y. Zeng, andA. K. Godwin, "Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology, " Lab on a Chip-Miniaturisation for Chemistry and Biology, vol. 14, no. 19, pp. 3773-3780, 2014.
64. J. Kowal, G. Arras, M. Colombo et al., "Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes, " Proceedings of the National Academy of Sciences, vol. 113, no. 8, pp. E968-E977, 2016.